Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · IEX Real-Time Price · USD
9.91
+0.32 (3.34%)
At close: Mar 28, 2024, 4:00 PM
9.88
-0.03 (-0.30%)
After-hours: Mar 28, 2024, 7:44 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.12 billion as of March 28, 2024. Its market cap has increased by 58.18% in one year.
Market Cap
1.12B
Enterprise Value
1.05B
1-Year Change
58.18%
Ranking
Category
Stock Price
$9.91
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $764.40M to $1.12B, an increase of 46.12%. That is a compound annual growth rate of 9.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 928.40M | 3.44% |
Mar 26, 2024 | 897.50M | 0.11% |
Mar 25, 2024 | 896.50M | -3.64% |
Mar 22, 2024 | 930.40M | -5.60% |
Mar 21, 2024 | 985.60M | -5.74% |
Mar 20, 2024 | 1.05B | 9.53% |
Mar 19, 2024 | 954.60M | -3.66% |
Mar 18, 2024 | 990.90M | -3.98% |
Mar 15, 2024 | 1.03B | -2.56% |
Mar 14, 2024 | 1.06B | -1.09% |
Mar 13, 2024 | 1.07B | 9.40% |
Mar 12, 2024 | 978.80M | 0.70% |
Mar 11, 2024 | 972.00M | -9.96% |
Mar 8, 2024 | 1.08B | 7.42% |
Mar 7, 2024 | 1.00B | -0.57% |
Mar 6, 2024 | 1.01B | -4.23% |
Mar 5, 2024 | 1.06B | -0.45% |
Mar 4, 2024 | 1.06B | -6.97% |
Mar 1, 2024 | 1.14B | 14.50% |
Feb 29, 2024 | 995.20M | -1.25% |
Feb 28, 2024 | 1.01B | -2.07% |
Feb 27, 2024 | 1.03B | 12.52% |
Feb 26, 2024 | 914.60M | 0.11% |
Feb 23, 2024 | 913.60M | 0.62% |
Feb 22, 2024 | 908.00M | 3.78% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Mirum Pharmaceuticals | 1.17B |
Sage Therapeutics | 1.15B |
MiMedx Group | 1.12B |
Verve Therapeutics | 1.10B |
Viridian Therapeutics | 1.10B |
Centessa Pharmaceuticals | 1.08B |
REGENXBIO | 1.08B |
BioCryst Pharmaceuticals | 1.06B |